Navigation Links
Chief Medical Officers in Biotechs Finally Have Their Own Conference
Date:1/31/2013

New York, New York (PRWEB) January 31, 2013

For the first time, Chief Medical Officers at biotechs will have their own conference thanks to the idea from Dr Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the organizer of the event says, “We are grateful to Dr Stoner’s idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs.”    

The Chief Medical Officer Summit takes place in Boston on May 6-7, 2013 and is dedicated to accomplishing two goals:

1. To bring together CMO executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital, working and meeting with investors and strategsing for appropriate exits.
2. To create a network of CMOs from small to mid size life science companies to share ideas, solutions and support.

Dr Steven Zelenkofske, CMO & SVP Clinical and Medical Affairs, Regado Biosciences and advisor to the program remarked, "I am excited about this conference and think it is very much needed."

Event Details: May 6-7, Boston, MA
The event organizers are offering a 10% discount with code CMOE and a pre-early bird rate before 3/1. Click here to register.

Program Overview and Agenda are available at http://www.theconferenceforum.org
Questions, please email service(at)theconferenceforum(dot)org

Speaking Faculty:
Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH
Mark Corrigan, MD, President & CEO, Zalicus
Anthony Coyle, PhD, VP & CSO, Centers for Therapeutic Innovation, Pfizer
Daniel Curran, MD, VP, Corporate Development, Millennium, Takeda Oncology
Greg Fiore, MD, CMO, The Medicines Company
Ken Getz, MBA, Senior Research Fellow, Tufts
Sheila Gujrathi, MD, CMO, Receptos
M. Scott Harris, MD, CMO, Avaxia Biologics; Principal, Middleburg Consultants; and Clinical Professor of Medicine, Georgetown University School of Medicine
Eric Hedrick, MD, CMO, Epizyme
Karin Hehenberger, MD, PhD, Executive Vice President & CMO, Coronado Biosciences
Dennis Kim, MD, MBA, CMO, Zafgen
Chris Kiritsy, MBA, President & CEO, Arisaph
Lori Kunkel, MD, CMO, Pharmacyclics
Tyler Martin, MD, President, CMO & Director, Dynavax Technologies
Robert Pyke, MD, PhD, CMO, S1 Biopharma
Jim Roach, MD, CMO & Senior Vice President, Development, Momenta Pharmaceuticals
Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
Jeffrey Sherman, MD, FACP, CMO & Executive Vice President, Development, Manufacturing, and Regulatory Affairs, Horizon Pharma
Greg Simon, CEO, Poliwogg
Elizabeth Stoner, MD, Managing Director, MPM Capital
Mary Szela, MBA, Senior Vice President, Pharmaceutical Operations, Abbott Laboratories
Santosh Vetticaden, MD, PhD, CMO, ADVENTRX Pharmaceuticals
Nancy Wetherbee, MBA, ORBIT Director, Tufts Medical Center
Steven Zelenkofske, DO, FACC, CMO & Senior Vice President, Clinical and Medical Affairs, Regado Bioscience

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10373318.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
2. Elsevier Welcomes New Editor-in-Chief for European Urology
3. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
4. Mobility and Big Data Analytics Provider NuWare Announces the Appointment of Rohit Shyam as Chief Strategy & Marketing Officer
5. Dr. Gil Ben-Menachem appointed Chief Executive Officer of OphthaliX Inc.
6. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
7. T1D Exchange Announces Appointment of Dana Ball as Chief Executive Officer
8. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
9. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
10. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
11. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 22, 2017 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), ... today announced it has issued a scientific white paper entitled “Results from recent ... of commentaries from ProMIS’s scientific team offering insight into the Company’s product portfolio ...
(Date:2/22/2017)... Feb. 22, 2017 Origin (Origin Agritech, LLC, a subsidiary ... seed provider, and Arcadia (Arcadia Biosciences, Inc., ... and commercializes agricultural productivity traits and nutritional products, today announced their ... product developed in China to ... ...
(Date:2/22/2017)... SAN DIEGO , Feb. 22, 2017 ... announced today expansion of its translational research program ... through establishment of laboratory facilities in San Diego.  ... San Diego BioLabs facility, a biotechnology incubator sponsored ... Sanofi. In November 2016, the Company ...
(Date:2/21/2017)... ... 2017 , ... During HIMSS 2017, CloudMine, a secure, cloud-based ... partnership with Redox, a leader in cloud-based healthcare integration and API services. The ... data secure in the cloud. , The digital health developers, and various healthcare ...
Breaking Biology Technology:
(Date:2/8/2017)... 7, 2017 Report Highlights ... The global synthetic-biology market reached ... by 2021, growing at a compound annual growth rate (CAGR) ... of the global markets for synthetic biology. - Analyses of ... and projections of compound annual growth rates (CAGRs) through 2021. ...
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):